title: Should we treat acute respiratory distress syndrome with inhaled nitric oxide?
authors.forename: E
authors.initials: E
authors.lastname: Troncy
authors.forename: J P
authors.initials: JP
authors.lastname: Collet
authors.forename: S
authors.initials: S
authors.lastname: Shapiro
authors.forename: J G
authors.initials: JG
authors.lastname: Guimond
authors.forename: L
authors.initials: L
authors.lastname: Blair
authors.forename: M
authors.initials: M
authors.lastname: Charbonneau
authors.forename: G
authors.initials: G
authors.lastname: Blaise
mesh_terms: D000280:Administration, Inhalation; D005240:Feasibility Studies; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy; D008168:Lung / Q000187:drug effects / Q000503:physiopathology; D008170:Lung Compliance / Q000187:drug effects; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use*; D010100:Oxygen / Q000097:blood; D010865:Pilot Projects; D011659:Pulmonary Gas Exchange / Q000187:drug effects; D012074:Remission Induction; D012121:Respiration, Artificial; D012126:Respiratory Dead Space / Q000187:drug effects; D012128:Respiratory Distress Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D015996:Survival Rate; D016896:Treatment Outcome; D014680:Veins; D015300:Ventilator Weaning
chemical_list: D009569:Nitric Oxide; D010100:Oxygen